Clinical Research Directory
Browse clinical research sites, groups, and studies.
Identification of a Biomarker Predictive of Evolution of Parkinson Disease
Sponsor: Nantes University Hospital
Summary
Phase II, Open-labeled, Prospective, Multi-center study of assessing the link between microglial activation and dopaminergic denervation kinetics in the early stage of Parkinson disease, by using the imaging of \[18F\]DPA-714 a new ligand of Translocator Protein-18 kDa (TSPO) by Positron Emission Tomography (PET).
Official title: Brain Microglial Activation in the Early Stage of the Parkinson's Disease: a Predictive Biomarker of the Evolution?
Key Details
Gender
All
Age Range
40 Years - 67 Years
Study Type
INTERVENTIONAL
Enrollment
31
Start Date
2018-04-16
Completion Date
2024-05-06
Last Updated
2024-04-25
Healthy Volunteers
No
Conditions
Interventions
[18F]DPA-714 PET scan
One PET scan using \[18F\]DPA-714 is done at M2 between two \[123I\]FP-CIT scan (DaTscan) done at M1 and M23. Neuropsychological assessment is done at M0, M18 and M24
Locations (4)
CHU de Nantes
Nantes, France
Centre Eugène Marquis
Rennes, France
CHU de Rennes
Rennes, France
CHU de Tours
Tours, France